Neurological Research and Practice
ISSN: 2524-3489
Publisher: BioMed Central
Publications (17)
Switch to tenecteplase for intravenous thrombolysis in stroke patients: experience from a German high-volume stroke center (2025)
Sekita A, Siedler G, Sembill J, Schmidt M, Singer L, Kallmünzer B, Mers L, et al.
Journal article
Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis (2025)
Huttner HB, Scherg F, Kopke K, Schultze M, Kossack N, Gerner ST, Kuramatsu J, Schwab S
Journal article
Acute care of aneurysmal subarachnoid hemorrhage: practical consensus statement from a multidisciplinary group of German-speaking neurointensivists and neuroradiologists on behalf of the DIVI neurology section (2025)
Kollmar R, Huttner HB, Ozpeynirci Y, Herweh C, Sembill J, Gerner S, Bender M, et al.
Journal article
Interdisciplinary neurovascular networks in Germany: update 2025 (2025)
Wagner-Altendorf TA, Sieb K, Berlis A, Dörfler A, Mielke D, Groden C, Güresir E, et al.
Journal article
Consensus on the clinical utility of digital mobility outcomes for personalized clinical decision support in parkinson’s disease (2025)
Mejia AC, Sapienza S, Paccoud I, Alcock L, Brown P, Gaßner H, Hunter H, et al.
Journal article
Endovascular thrombectomy in patients with anterior circulation stroke: an emulated real-world comparison (2024)
Sembill J, Sprügel M, Haupenthal D, Kremer S, Knott M, Mühlen I, Kallmünzer B, Kuramatsu J
Journal article
Patients’ and caregivers’ perception of multidimensional and palliative care in amyotrophic lateral sclerosis – protocol of a German multicentre study (2024)
Linse K, Weber C, Reilich P, Schöberl F, Boentert M, Petri S, Rödiger A, et al.
Journal article
Recommendations for the organization of the teleconsultation service in a telestroke network (2024)
Wiestler H, Zickler P, Erdur H, Abu-Mugheisib M, Kallmünzer B, Klingner C, Müller-Barna P, et al.
Journal article
Hematoma expansion in intracerebral hemorrhage – the right target? (2023)
Haupenthal D, Schwab S, Kuramatsu J
Journal article, Review article
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas (2022)
Bunse L, Rupp AK, Poschke I, Bunse T, Lindner K, Wick A, Blobner J, et al.
Journal article